INS and Hepatic steatosis: HFE homozygosity does not increase the risk for NAFLD [82] and iron accumulation in 65 NASH patients was not related to either overall or liver-related mortality or cirrhosis [83] and there was no improvement in hepatic steatosis or insulin sensitivity following 6 months of phlebotomy [84].